Yuichiro Inagaki
Overview
Explore the profile of Yuichiro Inagaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
202
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nishiwaki S, Terakura S, Morishita T, Goto T, Inagaki Y, Miyao K, et al.
Int J Hematol
. 2025 Jan;
PMID: 39821010
Post-transplant tyrosine kinase inhibitors (TKIs) show promise in preventing relapse after allogeneic hematopoietic cell transplantation (allo-HCT) for Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL). However, their real-world use and efficacy remain...
2.
Yokota H, Miyao K, Sawa M, Terakura S, Kurahashi S, Ikoma Y, et al.
J Hematol
. 2024 Sep;
13(4):142-149.
PMID: 39247063
Background: To investigate whether the addition of eltrombopag (EPAG) to rabbit anti-thymocyte globulin (ATG)-based immunosuppressive therapy (IST) for newly diagnosed severe aplastic anemia (SAA) improves outcomes and affects the cumulative...
3.
Barakat C, Inagaki Y, Mizuno S, Nishio N, Katsuyama N, Sato Y, et al.
Int J Hematol
. 2023 Jun;
118(2):252-266.
PMID: 37310580
Relapsed leukemia after allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains a significant challenge, with the re-emergence of the primary disease being the most frequent cause of death. Human leukocyte antigen...
4.
Kojima Y, Kawashima F, Yasuda T, Odaira K, Inagaki Y, Yamada C, et al.
Int J Hematol
. 2023 May;
118(1):65-74.
PMID: 37149540
Gene aberrations of B-cell regulators and growth signal components such as the JAK-STAT pathway are frequently found in B-cell acute lymphoblastic leukemia (B-ALL). EBF1 is a B-cell regulator that regulates...
5.
Takeuchi Y, Miyao K, Negishi S, Ohara F, Motegi K, Wakabayashi H, et al.
Transplant Cell Ther
. 2023 Feb;
29(5):325.e1-325.e10.
PMID: 36736783
Graft-versus-host disease (GVHD) is a major complication of allogeneic peripheral blood stem cell transplantation (PBSCT). Previous randomized studies have already shown that the use of several types of antihuman T...
6.
Negishi S, Miyao K, Ohara F, Motegi K, Wakabayashi H, Yokota H, et al.
Clin Exp Med
. 2022 Aug;
23(4):1285-1291.
PMID: 35976516
The effectiveness and safety of trimethoprim/sulfamethoxazole (TMP/SMX) desensitization therapy is insufficiently evaluated in hematological diseases. From 2002 to 2019, we retrospectively analyzed 112 patients with hematological diseases who underwent desensitization...
7.
Murakami S, Ri M, Ito M, Nakamura N, Kasahara S, Kitagawa J, et al.
Int J Hematol
. 2022 Jun;
116(4):563-569.
PMID: 35699890
The BLd regimen, which is a triplet regimen of bortezomib (Bor), lenalidomide (Len), and dexamethasone (Dex), is effective against newly diagnosed multiple myeloma (NDMM). However, non-hematological toxicities, such as peripheral...
8.
Tsuyuki Y, Kohno K, Inagaki Y, Sakai Y, Kosugi H, Takahashi E, et al.
J Clin Exp Hematop
. 2021 Sep;
61(3):173-179.
PMID: 34511545
Neoplastic programmed cell death ligand 1 (PD-L1) expression, activated by PD-L1 gene alterations, is strongly associated with classic Hodgkin lymphoma (CHL). This association enabled a diagnostic consensus for lymphocyte-depleted CHL...
9.
Shimada K, Yoshida K, Suzuki Y, Iriyama C, Inoue Y, Sanada M, et al.
Blood
. 2021 Jan;
137(11):1491-1502.
PMID: 33512416
Intravascular large B-cell lymphoma (IVLBCL) is a unique type of extranodal lymphoma characterized by selective growth of tumor cells in small vessels without lymphadenopathy. Greater understanding of the molecular pathogenesis...
10.
Nishida T, Kobayashi T, Sawa M, Masuda S, Shibasaki Y, Goto T, et al.
Ann Hematol
. 2021 Jan;
100(3):743-752.
PMID: 33427909
To overcome the delayed or failed engraftment after unrelated cord blood transplantation (CBT), we conducted a multicenter phase II study of intrabone single-unit CBT without antithymocyte globulin (ATG) for adult...